Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lacosamide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lacosamide 100mg tablets
0408010AHAAABAB
|
Lacosamide | Lacosamide | Central Nervous System | 23,618 |
|
Lacosamide 50mg tablets
0408010AHAAAAAA
|
Lacosamide | Lacosamide | Central Nervous System | 20,664 |
|
Lacosamide 200mg tablets
0408010AHAAADAD
|
Lacosamide | Lacosamide | Central Nervous System | 18,818 |
|
Lacosamide 150mg tablets
0408010AHAAACAC
|
Lacosamide | Lacosamide | Central Nervous System | 8,859 |
|
Lacosamide 10mg/ml oral solution sugar free
0408010AHAAAGAG
|
Lacosamide | Lacosamide | Central Nervous System | 5,055 |
|
Lacosamide 200mg/20ml solution for infusion vials
0408010AHAAAEAE
|
Lacosamide | Lacosamide | Central Nervous System | 2 |
|
Lacosamide 15mg/ml oral solution sugar free
0408010AHAAAFAF
|
Lacosamide | Lacosamide | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.